What is the address of DR WOUTERS & DR VAN POUCKE?

The registered office of DR WOUTERS & DR VAN POUCKE is located at Botermelkstraat 46, 9100 Sint-Niklaas.

Is DR WOUTERS & DR VAN POUCKE still active?

Yes. According to the CBE (1 October 2026) DR WOUTERS & DR VAN POUCKE is active, legal situation “Normale toestand”, started on 28 October 2008.

Is DR WOUTERS & DR VAN POUCKE registered on Peppol?

Yes, DR WOUTERS & DR VAN POUCKE is registered on the Peppol network with ID 0208:0807407709.

What is the enterprise number of DR WOUTERS & DR VAN POUCKE?

The enterprise number of DR WOUTERS & DR VAN POUCKE is BE0807407709.

When was DR WOUTERS & DR VAN POUCKE founded?

DR WOUTERS & DR VAN POUCKE was founded on 28 October 2008.

Who are the directors of DR WOUTERS & DR VAN POUCKE?

According to the 2025 annual accounts, the directors of DR WOUTERS & DR VAN POUCKE are: Karin Martha Van Poucke, Erik Alfons Wouters.

Is DR WOUTERS & DR VAN POUCKE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 October 2008; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR WOUTERS & DR VAN POUCKE make in 2025?

DR WOUTERS & DR VAN POUCKE posted a profit after taxes of € 598,897 in financial year 2025.

What is the revenue of DR WOUTERS & DR VAN POUCKE?

As a small company, DR WOUTERS & DR VAN POUCKE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 752,226.

How many employees does DR WOUTERS & DR VAN POUCKE have?

According to the 2025 annual accounts, DR WOUTERS & DR VAN POUCKE has 0 full-time equivalents (FTE).

DR WOUTERS & DR VAN POUCKE (Private Limited)

Dossier DR WOUTERS & DR VAN POUCKE, printed on 1 October 2026 from databakkes.be/en/0807407709/dr-wouters-dr-van-poucke. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR WOUTERS & DR VAN POUCKE from Sint-Niklaas, company number BE0807407709, closed financial year 2025 with a result of € 598,897 after tax. For that financial year DR WOUTERS & DR VAN POUCKE recorded a gross margin of € 752,226 and equity of € 7.3 million. Compared with financial year 2024, the result moved from € 842,267 to € 598,897. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 29, 2026.

What it is worth Growing

€ 7.3 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 598,897

▼ 29% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1.3 million

▲ 165% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 100,000 paid out

17 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 33,459

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 832

▲ 23% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 233,461

▼ 27% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 763,805 Gross margin 2022: € 763,805 First fiscal year in the series	€ 1,119,417 Gross margin 2023: € 1,119,417 ▲ 47% vs 2022 (€ 763,805) Favourable step	€ 1,090,329 Gross margin 2024: € 1,090,329 ▼ 3% vs 2023 (€ 1,119,417) Unfavourable step	€ 752,226 Gross margin 2025: € 752,226 ▼ 31% vs 2024 (€ 1,090,329) Unfavourable step	▼ 31%
Profit after taxes	€ 332,375 Profit after taxes 2022: € 332,375 First fiscal year in the series	€ 866,790 Profit after taxes 2023: € 866,790 ▲ 161% vs 2022 (€ 332,375) Favourable step	€ 842,267 Profit after taxes 2024: € 842,267 ▼ 3% vs 2023 (€ 866,790) Unfavourable step	€ 598,897 Profit after taxes 2025: € 598,897 ▼ 29% vs 2024 (€ 842,267) Unfavourable step	▼ 29%
Equity	€ 6,076,794 Equity 2022: € 6,076,794 First fiscal year in the series	€ 6,943,584 Equity 2023: € 6,943,584 ▲ 14% vs 2022 (€ 6,076,794) Favourable step	€ 6,769,681 Equity 2024: € 6,769,681 ▼ 3% vs 2023 (€ 6,943,584) Unfavourable step	€ 7,268,578 Equity 2025: € 7,268,578 ▲ 7% vs 2024 (€ 6,769,681) Favourable step	▲ 7%
Total debts	€ 185,095 Total debts 2022: € 185,095 First fiscal year in the series	€ 185,289 Total debts 2023: € 185,289 Unchanged (€ 185,095) Unfavourable step	€ 330,760 Total debts 2024: € 330,760 ▲ 79% vs 2023 (€ 185,289) Unfavourable step	€ 291,546 Total debts 2025: € 291,546 ▼ 12% vs 2024 (€ 330,760) Favourable step	▼ 12%
Cash	€ 3,316,469 Cash 2022: € 3,316,469 First fiscal year in the series	€ 1,138,974 Cash 2023: € 1,138,974 ▼ 66% vs 2022 (€ 3,316,469) Unfavourable step	€ 482,645 Cash 2024: € 482,645 ▼ 58% vs 2023 (€ 1,138,974) Unfavourable step	€ 1,278,413 Cash 2025: € 1,278,413 ▲ 165% vs 2024 (€ 482,645) Favourable step	▲ 165%
Retained profit	€ 6,053,794 Retained profit 2022: € 6,053,794 First fiscal year in the series	€ 6,920,584 Retained profit 2023: € 6,920,584 ▲ 14% vs 2022 (€ 6,053,794) Favourable step	€ 6,746,681 Retained profit 2024: € 6,746,681 ▼ 3% vs 2023 (€ 6,920,584) Unfavourable step	€ 7,245,578 Retained profit 2025: € 7,245,578 ▲ 7% vs 2024 (€ 6,746,681) Favourable step	▲ 7%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 1,016,170 Dividend 2024: € 1,016,170 Unchanged (€ 0) Unchanged	€ 100,000 Dividend 2025: € 100,000 ▼ 90% vs 2024 (€ 1,016,170) Unchanged	▼ 90%
Balance sheet total	€ 6,261,889 Balance sheet total 2022: € 6,261,889 First fiscal year in the series	€ 7,128,873 Balance sheet total 2023: € 7,128,873 ▲ 14% vs 2022 (€ 6,261,889) Unchanged	€ 7,100,441 Balance sheet total 2024: € 7,100,441 Unchanged (€ 7,128,873) Unchanged	€ 7,560,124 Balance sheet total 2025: € 7,560,124 ▲ 6% vs 2024 (€ 7,100,441) Unchanged	▲ 6%

Key figures of DR WOUTERS & DR VAN POUCKE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR WOUTERS & DR VAN POUCKE?

What happened at DR WOUTERS & DR VAN POUCKE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 29, 2026 New annual accounts for financial year 2025: profit of € 598,897 (▼ 29% vs 2024). filed late Source: NBB ↗
2023 Karin Martha Van Poucke became a director. NBB
2023 Erik Alfons Wouters became a director. NBB
Oct 28, 2008 New establishment in Sint-Niklaas. KBO
Oct 28, 2008 Start of the company according to the CBE. KBO

In short

From € 332,375 profit in 2022 to € 598,897 profit in 2025.

Paid € 1.5 million in corporate taxes since 2022.

Best year ever: 2023, with € 866,790 profit.

Paid out € 1.1 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR WOUTERS & DR VAN POUCKE? We notify you, reason included.

Follow DR WOUTERS & DR VAN POUCKE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Karin Martha Van Poucke Erik Alfons Wouters

DR WOUTERS & DR VAN POUCKE

Behind DR WOUTERS & DR VAN POUCKE are Karin Martha Van Poucke and Erik Alfons Wouters.

See the full network in the app

Directors

According to the 2025 annual accounts

Karin Martha Van Poucke

Director

since 2023

Erik Alfons Wouters

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Botermelkstraat 46

9100 Sint-Niklaas

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0807.407.709
VAT number: BE 0807.407.709
Registered office: Botermelkstraat 46, 9100 Sint-Niklaas
Names & denominations: DR WOUTERS & DR VAN POUCKE · DOKTERS W.V.P.
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 October 2008
Peppol: Active · Active since 1 Jan 2001

View on CBE Public ↗ Annual accounts (NBB) ↗